Sin Nombre hantavirus decreases survival of male deer mice.

Oecologia

Department of Biology, Center for Infectious Disease Dynamics, The Pennsylvania State University, University Park, PA, USA.

Published: June 2012

AI Article Synopsis

  • Understanding how pathogens like Sin Nombre virus (SNV) impact their hosts, particularly deer mice, can provide insights into disease spread and persistence.
  • Research over 15 years revealed that male deer mice with SNV antibodies had a 13.4% lower survival rate than uninfected mice, and infected breeding mice experienced even greater mortality.
  • The study suggests that SNV transmission depends on host population density, indicating that a critical density is necessary for the virus to persist, which contributes to the unpredictable nature of human infections.

Article Abstract

How pathogens affect their hosts is a key question in infectious disease ecology, and it can have important influences on the spread and persistence of the pathogen. Sin Nombre virus (SNV) is the etiological agent of hantavirus pulmonary syndrome (HPS) in humans. A better understanding of SNV in its reservoir host, the deer mouse, could lead to improved predictions of the circulation and persistence of the virus in the mouse reservoir, and could help identify the factors that lead to increased human risk of HPS. Using mark-recapture statistical modeling on longitudinal data collected over 15 years, we found a 13.4% decrease in the survival of male deer mice with antibodies to SNV compared to uninfected mice (both male and female). There was also an additive effect of breeding condition, with a 21.3% decrease in survival for infected mice in breeding condition compared to uninfected, non-breeding mice. The data identified that transmission was consistent with density-dependent transmission, implying that there may be a critical host density below which SNV cannot persist. The notion of a critical host density coupled with the previously overlooked disease-induced mortality reported here contribute to a better understanding of why SNV often goes extinct locally and only seems to persist at the metapopulation scale, and why human spillover is episodic and hard to predict.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00442-011-2219-2DOI Listing

Publication Analysis

Top Keywords

sin nombre
8
survival male
8
male deer
8
deer mice
8
better understanding
8
understanding snv
8
decrease survival
8
compared uninfected
8
breeding condition
8
critical host
8

Similar Publications

Background: Orthohantaviruses are negative-sense RNA viruses that can cause hantavirus cardiopulmonary syndrome (HCPS) in humans. In the United States, Sin Nombre orthohantavirus (SNV) is the primary cause of HCPS, with a fatality rate of 36% and most cases occuring in the southwestern states. The western deer mouse, Peromyscus sonoriensis, is the primary reservoir for SNV; however, it remains unclear if alternative reservoirs exist.

View Article and Find Full Text PDF

Specialized or secondary metabolites are small molecules of biological origin, often showing potent biological activities with applications in agriculture, engineering and medicine. Usually, the biosynthesis of these natural products is governed by sets of co-regulated and physically clustered genes known as biosynthetic gene clusters (BGCs). To share information about BGCs in a standardized and machine-readable way, the Minimum Information about a Biosynthetic Gene cluster (MIBiG) data standard and repository was initiated in 2015.

View Article and Find Full Text PDF
Article Synopsis
  • Research conducted on 3,400 febrile patients in Peru between 2020-2021 revealed a positive case of Rio Mamore hantavirus, highlighting the endemic presence of this virus in the region.
  • Genetic analysis showed a strong similarity to past rodent-associated hantavirus cases from Loreto, indicating ongoing circulation.
  • Findings suggest the need for enhanced hantavirus diagnostics and surveillance in Peru and Latin America due to the detection of multiple distinct hantavirus strains.
View Article and Find Full Text PDF
Article Synopsis
  • * SAB-163 is a new therapeutic treatment developed from transchromosomic bovine plasma, showing strong effectiveness against multiple hantavirus strains and extended bioavailability in animal models.
  • * The treatment has demonstrated protective effects in hamsters when administered around the time of exposure and is now ready for phase 1 clinical trials after passing safety and efficacy tests.
View Article and Find Full Text PDF
Article Synopsis
  • Hantavirus pulmonary syndrome (HPS) and non-HPS hantavirus infection are tracked as nationally notifiable diseases in the U.S., with diagnostics based on symptoms and lab results between 2008 and 2020.
  • A study merged epidemiological data and diagnostic lab results from the CDC to analyze the occurrence and genetic diversity of hantavirus in the U.S., revealing that the majority of cases were in western states, particularly the Four Corners region.
  • Findings highlight a seasonal spike in cases between March and August and reveal discrepancies between commercial and CDC lab tests, suggesting a need for better diagnostic tests to align results.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!